BioRestorative Therapies, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:BRTX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -2.35 M-2.78 M-2.69 M-2.9 M-2.42 M-3.81 M -11.82 M Cash from investing activities 1.53 M2.37 M2.13 M2 M2.4 M968.45 K 7.5 M Cash from financing activities -126.32 K1.09 M888.14 K-49.31 K923.24 K4.44 M 6.2 M Free cash flow -2.35 M-2.78 M-2.69 M-2.9 M-2.49 M-3.81 M -11.9 M

News

What Makes Biorestorative Therapies (BRTX) a New Buy Stock

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

BioRestorative Therapies closes $5 million public offering

BioRestorative Therapies earnings beat by $0.05, revenue fell short of estimates